VLO
48
-2
BK
68
-6
UAL
82
3
MMM
54
-3
EXR
22
-6
COP
40
-2
SJM
12
-4
SE
43
3
CCI
33
-5
APD
47
-2
ACN
52
-2
RL
75
-4
ILMN
68
-2
AEP
59
-5
VRSK
25
-3
FLR
40
-2
GE
70
-2
ORLY
40
-4
KR
29
-3
RIG
35
-6
VLO
48
-2
BK
68
-6
UAL
82
3
MMM
54
-3
EXR
22
-6
COP
40
-2
SJM
12
-4
SE
43
3
CCI
33
-5
APD
47
-2
ACN
52
-2
RL
75
-4
ILMN
68
-2
AEP
59
-5
VRSK
25
-3
FLR
40
-2
GE
70
-2
ORLY
40
-4
KR
29
-3
RIG
35
-6
Financhill
Back

CBRE Global Real Estate Income Fund Vs. Nektar Therapeutics Industry Stock Comparison

Sell
35

IGR
CBRE Global Real Estate Income Fund

Last Price:
$4.35
Seasonality Move:
-0.18%
Sell
42

NKTR
Nektar Therapeutics

Last Price:
$45.42
Seasonality Move:
11.58%
Sell
35
CBRE Global Real Estate Income Fund (IGR) is a Sell

Is CBRE Global Real Estate Income Fund a Buy, Sell or Hold?

  • The current CBRE Global Real Estate Income Fund [IGR] share price is $4.27. The Score for IGR is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • IGR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IGR Stock Price Chart

What is CBRE Global Real Estate Income Fund's stock price today?

  • The CBRE Global Real Estate Income Fund share price today is $4.27
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IGR is experiencing slight buying pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $49.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

IGR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 27.33 Sell
Chaikin Money Flow: 945253 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.34 - 4.74) Sell
Bollinger Bands (100): (4.64 - 5.12) Sell

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 38.92 Sell
Chaikin Money Flow: 341847 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.73 - 61.13) Sell
Bollinger Bands (100): (33.63 - 62.73) Buy

IGR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.29 Sell
20-day SMA: 4.47 Sell
50-day SMA: 4.75 Sell
200-day SMA: 4.97 Sell
8-day EMA: 4.31 Sell
20-day EMA: 4.46 Sell
50-day EMA: 4.57 Sell
200-day EMA: 3.02 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.87 Sell
20-day SMA: 57.43 Sell
50-day SMA: 58.05 Sell
200-day SMA: 31.04 Buy
8-day EMA: 54.11 Sell
20-day EMA: 56.28 Sell
50-day EMA: 55.42 Sell
200-day EMA: 38.13 Buy

CBRE Global Real Estate Income Fund Earnings Growth & IGR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

CBRE Global Real Estate Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):